Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Beijing
State: Beijing
Zip:
Country: China
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2022 | Series A | 1 | - |
Neovision Capital Neovision Capital |
3/2022 | Series A | 1 | $15.7M |
Yuanyi Investment Partnership Yuanyi Investment Partnership |
7/2022 | Series A | 1 | - |
Neovision Capital Neovision Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|